News Published: October 9, 2023

VERIGRAFT reports promising interim results from a first-in-man study in patients with deep venous insufficiency at 2023 Cell & Gene Meeting on the Mesa

Link to the article

Latest news

See all news

Published: March 2, 2026

VERIGRAFT expands its network within advanced therapy applications through EU-funded Doctoral Network VISI-ON-BRAIN

Uncategorized Published: February 12, 2026

VERIGRAFT announces a committed capital contribution of SEK 110 million to advance pivotal trial program in Europe and the US

Uncategorized Published: February 10, 2026

Technology collaboration with South Korea

Published: February 4, 2026

VERIGRAFT Q4 2025 – Clinical Milestone in Ongoing Development

Published: February 2, 2026

VERIGRAFT Submits Application for Pivotal Phase II/III Clinical Trial in Europe

Published: December 3, 2025

First-in-Human Results for VERIGRAFT’s Individualized Tissue-Engineered Vein (P-TEV) in Severe CVI